Literature DB >> 16757597

Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France.

Jean-François Cantaloube1, Syria Laperche, Pierre Gallian, Françoise Bouchardeau, Xavier de Lamballerie, Philippe de Micco.   

Abstract

The 5' noncoding region (5' NCR) of the hepatitis C virus (HCV) has become the standard for genotyping even though several reports show that its use can result in classification errors. The purpose of this study was to perform genotyping based on sequence analysis of the NS5b region in a set of 357 HCV strains isolated from blood donors in France in 2002 and 2003. Results were compared with those previously obtained using 5' NCR analysis, and HCV subtype distribution was reevaluated. Twenty-six of 120 strains (approximately 22%) initially identified as genotype 1b by 5' NCR region sequence analysis were reclassified as genotype 1a by NS5b region sequence analysis. Similarly, 14 of 23 strains (approximately 61%) initially identified as 2a/2c were reclassified as non-2a and non-2c subtypes, and 12 of 22 strains (approximately 45%) initially identified as 4c/4d subtypes were reclassified as non-4c and non-4d subtypes. Sequence analysis of the NS5b region also revealed 5 putative new subtype 2 variants and 2 putative new subtype 4 variants. Although these findings demonstrated full agreement between 5' NCR and NS5b sequence analysis with regard to type classification, genotyping based on phylogenetic analysis of the NS5b region is more accurate for subtype determination than genotyping based on analysis of the 5' NCR. Sequence analysis of the NS5b region is mandatory for epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757597      PMCID: PMC1489428          DOI: 10.1128/JCM.02463-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

Authors:  L Stuyver; W van Arnhem; A Wyseur; F Hernandez; E Delaporte; G Maertens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

2.  Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy.

Authors:  B Robertson; G Myers; C Howard; T Brettin; J Bukh; B Gaschen; T Gojobori; G Maertens; M Mizokami; O Nainan; S Netesov; K Nishioka; T Shin i; P Simmonds; D Smith; L Stuyver; A Weiner
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

3.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

4.  Genetic organization and diversity of the hepatitis C virus.

Authors:  Q L Choo; K H Richman; J H Han; K Berger; C Lee; C Dong; C Gallegos; D Coit; R Medina-Selby; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

5.  Heterogeneity of hepatitis C virus genotypes in France.

Authors:  D Qu; O Hantz; M Gouy; L Vitvitski; J S Li; F Berby; S P Tong; C Trépo
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

6.  Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

Authors:  G Inchauspe; S Zebedee; D H Lee; M Sugitani; M Nasoff; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4.

Authors:  Jenny Martial; Yoann Morice; Sylvie Abel; André Cabié; Christelle Rat; Frédéric Lombard; André Edouard; Serge Pierre-Louis; Philippe Garsaud; Odile Béra; Roger Chout; Emmanuel Gordien; Paul Deny; Raymond Césaire
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups.

Authors:  H Tokita; H Okamoto; H Iizuka; J Kishimoto; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1998-08       Impact factor: 3.891

9.  Evaluation of the TRUGENE HCV 5'NC genotyping kit with the new GeneLibrarian module 3.1.2 for genotyping of hepatitis C virus from clinical specimens.

Authors:  Jeffrey J Germer; David W Majewski; Michael Rosser; Amber Thompson; P Shawn Mitchell; Thomas F Smith; Slava Elagin; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 10.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

View more
  23 in total

1.  Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes.

Authors:  Mouna Rajhi; Selma Mejri; Ahlem Djebbi; Soufiene Chouaieb; Imed Cheikh; Ahlem Ben Yahia; Amel Sadraoui; Walid Hammami; Msaddak Azouz; Nabil Ben Mami; Henda Triki
Journal:  Virus Genes       Date:  2013-11-23       Impact factor: 2.332

2.  Correlation Study Between HCV Genotypes Distribution Pattern and Viral Load in a Tertiary Care Hospital in Kolkata, India.

Authors:  Debojyoti Bhattacharjee; Kheya Mukherjee; Goutam Chakroborti; Ranadeep Ghosh; Nabarun Mandal; Mohua Bose
Journal:  J Clin Diagn Res       Date:  2015-05-01

3.  Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping.

Authors:  Chen-Hua Liu; Cheng-Chao Liang; Chun-Jen Liu; Chih-Lin Lin; Tung-Hung Su; Hung-Chih Yang; Pei-Jer Chen; Ding-Shinn Chen; Jia-Horng Kao
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

4.  Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.

Authors:  Michael O Baclig; Veronica F Chan; John Donnie A Ramos; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-07

Review 5.  Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review.

Authors:  Rushna Firdaus; Kallol Saha; Aritra Biswas; Provash Chandra Sadhukhan
Journal:  World J Virol       Date:  2015-02-12

6.  Development of hepatitis C virus genotyping by real-time PCR based on the NS5B region.

Authors:  Sueli M Nakatani; Carlos A Santos; Irina N Riediger; Marco A Krieger; Cesar A B Duarte; Marco A Lacerda; Alexander W Biondo; Flair J Carrilho; Flair J Carilho; Suzane K Ono-Nita
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Anti-HCV reactive volunteer blood donors distribution character and genotypes switch in Xi'an, China.

Authors:  Qiao-hong Yue; Xian-qing Zhang; Yu Shang; Yao-zhen Chen; Wen-li Sun; Min-quan Su; Shi-jie Mu; Xiao-ke Hao; Xing-bin Hu
Journal:  Virol J       Date:  2010-08-10       Impact factor: 4.099

8.  Investigation of putative multisubtype hepatitis C virus infections in vivo by heteroduplex mobility analysis of core/envelope subgenomes.

Authors:  Hui Li; Lisa V Thomassen; Ayaz Majid; Brian J McMahon; Dana Bruden; Susan McArdle; Nazneen Bano; Minjun Chung; Robert L Carithers; James D Perkins; Daniel G Sullivan; David R Gretch
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

9.  Hepatitis C virus genotyping methods: evaluation of AmpliSens(®) HCV-1/2/3-FRT compared to sequencing method.

Authors:  Nurul Azmawati Mohamed; Zetti Zainol Rashid; Kon Ken Wong
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

10.  Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories.

Authors:  R S Ross; S Viazov; S S Kpakiwa; M Roggendorf
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.